Mitsue Saito, Hirotoshi Iihara, Mototsugu Shimokawa, Ryoko Udagawa, Michiko Tsuneizumi, Manabu Futamura, Yuko Ishikawa, Hideaki Ogata, Hiroko Bando, Hiroaki Shima, et al. Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial. The Lancet. Oncology. 2025
Koki Hara, Wakana Chikaishi, Yunami Yamada, Hironori Fujii, Jesse Yu Tajima, Hirotoshi Iihara, Akitaka Makiyama, Daichi Watanabe, Koichi Ohata, Chiemi Hirose, et al. Geriatric 8 score as a prognostic factor of the efficacy and safety of oxaliplatin-based chemotherapy in elderly patients with metastatic colorectal cancer. International journal of colorectal disease. 2025. 40. 1. 132-132
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, Miki Chin, Daisuke Hirate, Katsuyuki Takahashi, Makiko Go, Toshihiro Kudo, Kazuhiro Shimomura, Yosuke Ando, et al. Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025. 33. 6. 469-469
Yeon Hee Park, Giampaolo Bianchini, Javier Cortés, Luca Licata, María Vidal, Hirotoshi Iihara, Eric J Roeland, Karin Jordan, Florian Scotté, Lee Schwartzberg, et al. Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. Future oncology (London, England). 2025. 1-12
Yunami Yamada, Hirotoshi Iihara, Akihito Nagano, Hironori Fujii, Masanori Tsugita, Ryo Hoshino, Koki Hara, Ryo Kobayashi, Haruhiko Akiyama, Akio Suzuki. Efficacy of triplet antiemetic prophylaxis against chemotherapy-induced nausea and vomiting in patients with soft tissue sarcomas receiving consecutive-day doxorubicin and ifosfamide therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025. 33. 4. 274-274
Efficacy of 5mg olanzapine for ac regimen focusing on safe hospital visits: a double-blind, randomized, placebo-controlled trial
(MASCC/ISOO 2025 Annual Meeting, Seattle, 2025 2025)
Are immune-relaed adverse events associated with survival in patients treated with immune checkpoint inhibitor plus chemothrapy for lung cancer?
(MASCC/ISOO 2025 Annual Meeting, Seattle, 2025 2025)
Incidence and prognostic impact of cancer cachexia based on asian and european criteria in metastatic colorectal cancer chemotherapy
(MASCC/ISOO 2025 Annual Meeting, Seattle, 2025 2025)
Healthcare provider experiences in managing antibody-drug conjugate dosing adjustments due to nausea and vomiting: SABCS and ESMO survey findings.
(The 2025 ASCO Annual Meeting)
2022/04 - 現在 The Multinational Association of Supportive Care in Cancer (MASCC)/ European Society For Medical Oncology (ESMO) Antiemetic Guideline Update Committee member
2023/11 - 一般社団法人日本医療薬学会 JPHCS 誌 論文賞 Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy
2022/07 - 第68回 日本薬学会東海支部総会・大会 学生優秀演題賞 オキサリプラチン投与時のデキサメタゾンによる pH 調整が血管痛の VAS に与える影響
2022/06 - 日本がんサポーティブケア学会 優秀演題賞 Patient-reported outcomes with dexamethasone sparing in CDDP-based chemotherapy: A randomized, placebo-controlled, phase III study (SPARED trial)
2019/09 - ESMO Congress 2019 Best Poster A phase III trial evaluating olanzapine 5 mg for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin: J-FORCE Study
2019/06 - American Society of Clinical Oncology Best of ASCO A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin based chemotherapy
2009/04 - MD Anderson Cancer Center Japanese Medical Exchange Program 2009 (MDアンダーソンがんセンターへの留学研修プログラム)
全件表示
所属学会 (11件):
International Society of Oncology Pharmacy Practitioners (ISOPP)
, 日本がん薬剤学会
, European Society for Medical Oncology
, Multinational Association of Supportive Care in Cancer
, 日本がんサポーティブケア学会
, 日本臨床薬理学会
, 日本癌治療学会
, 臨床腫瘍薬学会
, 日本薬学会
, 日本臨床腫瘍学会
, 日本医療薬学会